Patent details

EP3713928 Title: NOVEL BRADYKININ B2 RECEPTOR ANTAGONISTS

Basic Information

Publication number:
EP3713928
PCT Application Number:
EP2018082338
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP188189922
PCT Publication Number:
WO2019101906
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
NOVEL BRADYKININ B2 RECEPTOR ANTAGONISTS
French Title of Invention:
NOUVEAUX ANTAGONISTES DES RÉCEPTEURS DE BRADYKININE B2
German Title of Invention:
NEUARTIGE BRADYKININ-B2-REZEPTOR-ANTAGONISTEN
SPC Number:

Dates

Filing date:
23/11/2018
Grant date:
12/01/2022
EP Publication Date:
30/09/2020
PCT Publication Date:
31/05/2019
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
12/01/2022
EP B1 Publication Date:
12/01/2022
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
23/11/2038
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
05/01/2022
 
 

Name:
Pharvaris Netherlands B.V.
Address:
Leiden BioScience Park J.H. Oortweg 21, 2333 CH Leiden, Netherlands (NL)

Agent

Name:
ARONOVA S.A.
From:
10/03/2022
Address:
PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Inventor

1

Name:
SAUPE, Joern
Address:
Germany (DE)

2

Name:
HAUSTEDT, Lars Ole
Address:
Germany (DE)

3

Name:
GIBSON, Christoph
Address:
Germany (DE)

4

Name:
AMBROSI, Horst-Dieter
Address:
Germany (DE)

Priority

Priority Number:
17203675
Priority Date:
24/11/2017
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
C07D 401/14; C07D 405/14; C07D 413/14; C07D 401/04; C07D 417/14; A61P 25/28; A61P 29/00; A61P 11/06; A61K 31/5377; A61K 31/4709;

Publication

European Patent Bulletin

1

Issue number:
202202
Publication date:
12/01/2022
Description:
Grant (B1)

2

Issue number:
202203
Publication date:
19/01/2022
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
30/11/2026
Annual Fee Number:
9
Annual Fee Amount:
115 Euro
Expected Payer:
Last Annual Fee Payment Date:
18/11/2025
Last Annual Fee Paid Number:
8
Last Annual Fee Paid Amount:
99 Euro
Payer:
PAVIS GMBH
Filing date Document type Number of pages
10/03/2022 Power Of Attorney 1
11/03/2022 Outgoing Correspondence 1